| Literature DB >> 28412383 |
B Risslegger1, T Zoran1, M Lackner1, M Aigner1, F Sánchez-Reus2, A Rezusta3, A Chowdhary4, S J Taj-Aldeen5, M C Arendrup6, S Oliveri7, D P Kontoyiannis8, A Alastruey-Izquierdo9, K Lagrou10, G Lo Cascio11, J F Meis12, W Buzina13, C Farina14, M Drogari-Apiranthitou15, A Grancini16, A M Tortorano17, B Willinger18, A Hamprecht19, E Johnson20, L Klingspor21, V Arsic-Arsenijevic22, O A Cornely23, J Meletiadis24, W Prammer25, V Tullio26, J-J Vehreschild27, L Trovato28, R E Lewis29, E Segal30, P-M Rath31, P Hamal32, M Rodriguez-Iglesias33, E Roilides34, S Arikan-Akdagli35, A Chakrabarti36, A L Colombo37, M S Fernández38, M T Martin-Gomez39, H Badali40, G Petrikkos41, N Klimko42, S M Heimann43, J Houbraken44, O Uzun45, M Edlinger46, S de la Fuente47, C Lass-Flörl48.
Abstract
OBJECTIVES: A prospective international multicentre surveillance study was conducted to investigate the prevalence and amphotericin B susceptibility of Aspergillus terreus species complex infections.Entities:
Keywords: Amphotericin B; Aspergillosis; Aspergillus terreus; Crytic species; In vitrosusceptibility
Mesh:
Substances:
Year: 2017 PMID: 28412383 DOI: 10.1016/j.cmi.2017.04.012
Source DB: PubMed Journal: Clin Microbiol Infect ISSN: 1198-743X Impact factor: 8.067